Abstract:Osteoporosis is a global chronic disease characterized by severe bone loss and high susceptibility to fragile fracture. It is widely accepted that the origin acidified microenvironment created by excessive osteoclasts causes irreversible bone mineral dissolution and organic degradation during osteoclastic resorption. However, current clinically available approaches are mainly developed from the perspective of osteoclast biology rather than the critical acidified niche. Here, we developed a smart "nanosacrificial layer" consisting of sodium bicarbonate (NaHCO3)-containing and tetracycline-functionalized nanoliposomes (NaHCO3–TNLs) that can target bone surfaces and respond to external secreted acidification from osteoclasts, preventing osteoporosis. In vitro and in vivo results prove that this nanosacrificial layer precisely inhibits the initial acidification of osteoclasts and initiates a chemically regulated biocascade to remodel the bone microenvironment and realize bone protection: extracellular acid–base neutralization first inhibits osteoclast function and also promotes its apoptosis, in which the apoptosis-derived extracellular vesicles containing RANK (receptor activator of nuclear factor-κ B) further consume RANKL (RANK ligand) in serum, achieving comprehensive osteoclast inhibition. Our therapeutic strategy for osteoporosis is based on original and precise acid–base neutralization, aiming to reestablish bone homeostasis by using a smart nanosacrificial layer that is able to induce chemically regulated biocascade effects. This study also provides a novel understanding of osteoporosis therapy in biomedicine and clinical treatments.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c07309?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c07309</a>.FTIR spectra, fluorescence images, FITC standard curve, high-resolution TEM image, electron diffraction pattern, SEM images, in vivo fluorescence images, pH values of NaHCO3–TNLs, pH value within the acidic milieu of osteoclasts, osteoclasts endocytosis rate, CCK-8 assay and staining results, flow cytometry results, micro-CT evaluation, and calcein double-labeling experiment results (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c07309/suppl_file/ja0c07309_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

[Therapeutic agents for disorders of bone and calcium metabolism: Minodronic acid hydrate]

Development of Minodronic Acid-Loaded Dissolving Microneedles for Enhanced Osteoporosis Therapy: Influence of Drug Loading on the Bioavailability of Minodronic Acid

Self-assembling Bisphosphonates into Nanofibers to Enhance Their Inhibitory Capacity on Bone Resorption.

Technetium-99 Conjugated with Methylene Diphosphonate Ameliorates Ovariectomy-Induced Osteoporotic Phenotype Without Causing Osteonecrosis in the Jaw

Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene

Latest on Anabolic Agents for Osteoporosis Treatment

Synthesis and Evaluation of a Novel Series of Diphenylamine and Diphenylether Derivatives with Osteoblastogenic and Osteogenic Effects via CDK8 Inhibition

Abaloparatide: research progress of a new anabolic agent for osteoporosis

Alendronate carbon dots targeting bone immune microenvironment for the treatment of osteoporosis

[The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis]

pH-Sensitive nanocarrier assisted delivery of adenosine to treat osteoporotic bone loss

RANKL as a target for the treatment of osteoporosis

Acid Neutralization and Immune Regulation by Calcium–Aluminum-Layered Double Hydroxide for Osteoporosis Reversion

Attenuating osteoarthritis by a high efficient anti-bone resorption injectable pH-responsive bisphosphonate-conjugated nano-apatite system

Inhibitory Effect and Cell Mechanism of BM_(210955) on Bone Resorption

Effect of 5 Mg Zoledronic Acid on Bone Mineral Density in Women with Postmenopausal Osteoporosis

Smart Nanosacrificial Layer on the Bone Surface Prevents Osteoporosis through Acid–Base Neutralization Regulated Biocascade Effects

The Beneficial Effects of Bisphosphonate-enoxacin on Cortical Bone Mass and Strength in Ovariectomized Rats

Synthesis and characterization of novel denosumab/magnesium-based metal organic frameworks nanocomposite prepared by ultrasonic route as drug delivery system for the treatment of osteoporosis

The use of denosumab in osteoporosis - an update on efficacy and drug safety

[A Randomized Double-Blinded Placebo-Controlled Clinical Trial of Minodronate Tablet in Postmenopausal Chinese Women with Osteoporosis].